SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-17-051041
Filing Date
2017-08-10
Accepted
2017-08-10 16:05:58
Documents
4
Effectiveness Date
2017-08-10

Document Format Files

Seq Description Document Type Size
1 S-8 a17-18758_1s8.htm S-8 90125
2 EX-5.1 a17-18758_1ex5d1.htm EX-5.1 7831
3 EX-10.1 a17-18758_1ex10d1.htm EX-10.1 143038
4 EX-23.1 a17-18758_1ex23d1.htm EX-23.1 3829
  Complete submission text file 0001104659-17-051041.txt   246043
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-219869 | Film No.: 171021494
SIC: 2835 In Vitro & In Vivo Diagnostic Substances